Guardant Health (FRA:5GH) Tax Rate % : -0.35% (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Guardant Health Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Guardant Health's Tax Expense for the three months ended in Mar. 2024 was €0.4 Mil. Guardant Health's Pre-Tax Income for the three months ended in Mar. 2024 was €-105.4 Mil. Therefore, Guardant Health's Tax Rate % for the quarter that ended in Mar. 2024 was -0.35%.

Guardant Health Tax Rate % Historical Data

The historical data trend for Guardant Health's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardant Health Tax Rate % Chart

Guardant Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Rate %

Get a 7-Day Free Trial

2.69

-0.15

-0.08

-0.17

-0.14

Guardant Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Tax Rate %	Get a 7-Day Free Trial															-0.18	-0.69	-0.57	0.29	-0.35

Guardant Health Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Guardant Health's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %	=	Tax Expense (A: Dec. 2023 )	/	Pre-Tax Income (A: Dec. 2023 )
	=	0.628	/	-439.027
	=	-0.14 %

Guardant Health's Tax Rate % for the quarter that ended in Mar. 2024 is calculated as

Tax Rate %	=	Tax Expense (Q: Mar. 2024 )	/	Pre-Tax Income (Q: Mar. 2024 )
	=	0.373	/	-105.414
	=	-0.35 %

Guardant Health Tax Rate % Related Terms

Thank you for viewing the detailed overview of Guardant Health's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.

Guardant Health (FRA:5GH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guardant Health Inc (FRA:5GH) » Definitions » Tax Rate %

Comparable Companies

Traded in Other Exchanges

GH:USA

Address

3100 Hanover Street, Palo Alto, CA, USA, 94304

Website

https://www.guardanthealth.com

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Guardant Health (FRA:5GH) Headlines

No Headlines